Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study Comparing Abemaciclib and Fulvestrant with Placebo and Fulvestrant for Patients with Advanced or Metastatic Breast Cancer After Previous Treatment

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark France Greece Hungary +3
  • Study of Daratumumab, Pomalidomide, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    Italy
  • Study on the Use of Human Normal Immunoglobulin for Preventing Infections in Patients with Chronic Lymphocytic Leukemia and Secondary Immunodeficiency

    Not recruiting

    1 1 1
    Czechia Denmark Greece Hungary Italy Poland +1
  • Study on the Effectiveness and Safety of Osimertinib for Patients with EGFR Mutation-Positive Stage II-IIIB Non-Small Cell Lung Cancer After Tumor Removal

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy Spain
  • Study on the Safety and Effectiveness of Vepdegestrant and Samuraciclib for Adults with ER+ Advanced or Metastatic Breast Cancer

    Not recruiting

    1 1
    Belgium France Italy Spain
  • Study on the Effects of Human Serum Albumin on Survival in Patients with Severe Acute-On-Chronic Liver Failure

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Croatia France Germany +5
  • Study on the Safety and Efficacy of Viltolarsen for Boys with Duchenne Muscular Dystrophy

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Greece Italy The Netherlands Norway Spain
  • Long-term Safety Study of KVD900 for Treating Angioedema Attacks in Adolescents and Adults with Hereditary Angioedema Type I or II

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Bulgaria France Germany Greece Hungary +7
  • Study on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment

    Not recruiting

    1 1 1 1
    Austria Belgium Czechia Denmark Finland France +9
  • Study of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma

    Not recruiting

    1 1 1
    Investigated diseases:
    France Hungary The Netherlands Poland Spain